Safety and efficacy of eblasakimab, an interleukin 13 receptor α1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: A phase 1b, multiple-ascending dose study
Related Posts
Maas D, Spindler A, Klufas T, Kamat S, Zappi I, Zhou AE, Lo Sicco KI, Flamm A, Grant-Kels JM. Dermatologic Procedural Patterns in Medicaid Billing[...]
Martínez-Hidalgo P, Hirsch AM, Rubbi L, Del Vecchio G, Ha SM, Pellegrini M, Humm E, Gunsalus RP. Complete genomes of Micromonospora sp. Utrum1 and Micromonospora reichwaldensis USAFONa4. Microbiol Resour[...]
Freeman M, Gates G, Ahronowitz I. Decade Growing in Plain Sight: Detection of an Invasive Melanoma Within a Long-Standing Pigmented Lesion. Cureus. 2026 Oct 10;18(10):e117734.[...]